The Libido Shift: Why Desire Changes—and What Helps
Low libido is one of the common—and often frustrating—symptoms women experience during the menopause transition. It is frequently misunderstood, under-discussed, and sometimes dismissed. For many women, the change can feel confusing, deeply personal, and difficult to put into words.
How Common Is Low Libido?
Low sexual desire can occur at any stage of life, but it becomes significantly more common in midlife. Up to 50% of women report periods of low libido during the perimenopausal and menopausal years.
Importantly, not all low desire is a problem. What matters is whether it feels distressing. About 12% of women ages 45–64 experience symptoms significant enough to meet criteria for Hypoactive Sexual Desire Disorder (HSDD).
What Is HSDD?
HSDD is low libido that causes distress. It is defined by:
• persistent or recurrent lack of sexual desire
• reduced or absent sexual thoughts and fantasies
• significant personal distress or relationship strain
In real life, this can present as a woman who previously enjoyed sex but now feels that her desire has faded—or disappeared entirely. This shift can affect mood, self-esteem, and connection with a partner. She may feel like this important part of her life is missing and would like to get it back.
It’s important to understand that HSDD is a clinical diagnosis. There is no lab test or “cutoff” testosterone level that defines it.
Why Does Libido Change During Perimenopause?
Libido is not driven by hormones alone—it reflects a complex interplay of biology, psychology, and relationships.
Common contributors include:
• Hormonal and brain chemical fluctuations that shift the balance between sexual excitation and inhibition
• Chronic medical conditions (e.g., diabetes, pain, hypertension)
• Medications (antidepressants, oral contraceptives, blood pressure drugs)
• Mental health factors like stress, anxiety, and depression
• Relationship dynamics, life demands, and body image changes
What Can Help?
Because the causes are multifactorial, treatment is usually layered and individualized.
Testosterone therapy is one of the evidence-based options. A large 2019 Lancet study showed that women taking testosterone had improvements in the following sexual function domains compared to women who did not take the medication:
• ~1 additional satisfying sexual event per month
• improvements in desire, arousal, orgasm, and pleasure
• reduced sexual distress
It’s important to set expectations that testosterone is not a magic fix. About 52% of women respond to testosterone treatment.
While testosterone is not FDA-approved for women, several guidelines support low-dose use (about 1/10th of male dosing), typically as a transdermal gel or cream. We avoid using pellets in our practice because they can create supraphysiological high levels.
FDA-Approved Medications
For women who cannot or prefer not to use testosterone:
Flibanserin (Addyi)
• daily oral medication
• works on brain chemistry (not hormones)
• takes ~4–8 weeks to work
• ~58% response rate
• modest but meaningful improvements
Bremelanotide (Vyleesi)
• on-demand injection (pen device)
• used ~45 minutes before sexual activity
• also works on central brain pathways of desire
• similar efficacy to Addyi and testosterone
• offers flexibility (not a daily medication)
Looking Beyond Medications
Medications are only part of the picture. Often, the biggest improvements come from addressing underlying contributors.
High-impact areas include:
• Reviewing medications that may suppress libido
• Treating genitourinary syndrome of menopause (GSM). Read more about GSM in our blog
• Pelvic floor physical therapy for pain and muscle tension
• Sex therapy for communication, intimacy, and desire
• Addressing stress, anxiety, and depression
The Bottom Line
Low libido during perimenopause is common and often multifactorial.
If you feel like you’ve lost a meaningful part of your life—something that once brought connection, pleasure, or a sense of self—there are options.
And you don’t have to navigate this alone.
